Download Nutrition_445_Case_Study_3

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Low-carbohydrate diet wikipedia , lookup

Human nutrition wikipedia , lookup

Dietary fiber wikipedia , lookup

Obesogen wikipedia , lookup

Dieting wikipedia , lookup

DASH diet wikipedia , lookup

Nutrition wikipedia , lookup

Epidemiology of metabolic syndrome wikipedia , lookup

Saturated fat and cardiovascular disease wikipedia , lookup

Atherosclerosis wikipedia , lookup

Transcript
Jared Markus
Nutrition 445
Case Study 3
Due April 6, 2016
Hypercholesterolemia:
A 36-year old man was found to have hypercholesterolemia. A dietary evaluation indicated that
he was consuming about 600 mg/day of cholesterol. His plasma cholesterol concentration on
two separate occasions was approximately 330 mg/dL (8.5 mmol/L). Ultracentrifugal analysis
revealed that the cholesterol elevation was due to an increase in plasma LDL. He was treated
with a cholesterol-free vegetarian diet for 3 months, but his plasma cholesterol level decreased to
only 300 mg/dL (7.7 mmol/L). Subsequently he was treated with colestipol hydrochloride, a bile
acid-binding resin that is not absorbed. This treatment lowered the fasting plasma cholesterol
concentration to 250 mg/dL (6.4 mmol/L).
Questions:
1. How is dietary cholesterol absorbed?
Dietary cholesterol is absorbed in two steps, first the cholesterol enters the lumen where
it is digested and put through hydrolysis. These dietary lipids are then put through
solubilization (in the micelles) from phospholipids and bile acid, and allows the
cholesterol to move to the surface of the enterocyte. Secondly, the body uses simple and
facilitated diffusion to move cholesterol across the mucosal cell membrane and to a
transporter for cholesterol within the microvillus membrane where it is esterified once
again. The cholesterol ends up becoming apolipoprotein B and is secreted into the lymph.
(Turley & Dietschy)
(Altmann)
2. How is it possible for a patient to continue to have high plasma cholesterol after being on
a cholesterol-free diet for 3 months?
It is possible to have high plasma cholesterol after being on a cholesterol-free diet
for 3 months due to your body making a certain amount itself as a natural function. If the
patient stops eating cholesterol, and yet still have high plasma cholesterol, they more than
likely are not living a healthy lifestyle. With this being said, they are either obese, high
cholesterol was inherited, low physical activity or getting older. Obesity and as a person
ages, they are dealt with the rise of LDL cholesterol and a decrease in HDL cholesterol.
The diet will not help if they are not physical active on a regular basis, due to the rise of
HDL cholesterol when your body is under a copious amount of physical activity.
(Kresser)
If it was inherited, the patient should be aware of this and know not only do they
need to watch the amount of cholesterol consumed, but also take proper cautions as to
medications and the standard amount of physical activity. Other than lifestyle, the
discontinuation of consuming cholesterol will ultimately take a toll on how the body
regulates cholesterol and how much it produces. With that being said, the number of
lipoprotein receptors, and hence the efficiency of disposal of plasma cholesterol, can be
increased by cholesterol-lowering drugs. Regulation of lipoprotein receptors can be
exploited pharmacologically in the therapy of hypercholesterolemia and atherosclerosis is
man. (Brown)
3. What connection is there between bile acids and cholesterol?
The connection between bile acids and cholesterol is simply that bile acids allow
cholesterol to be regulated and absorbed. “Data are presented which show that bile acids,
the major steroids circulating in this cycle, exert direct feedback control of hepatic
cholesterol synthesis. This characteristic of bile acids may explain why certain bile acids,
when given orally, reduce serum cholesterol levels.” (Barth)
4. How does a bile acid-binding resin lower the plasma cholesterol concentration?
The bile acid-binding resin lower the plasma cholesterol concentration due to the
highly positively charged molecules that bind with the negatively charged bile acids. This
disables cholesterol absorption by inhibiting their solubilization. “They also inhibit the
reabsorption of bile acids (which is typically 95%) and thus cause a contraction of the
bile acid pool which leads to increased bile acid synthesis that competes with cholesterol
synthesis in the liver, which also contributes to the lowering of serum cholesterol levels.”
(National Institute of Diabetes and Digestive and Kidney Diseases)
5. What additional treatment would you suggest for a patient with this disease?
The additional treatment suggested for a patient with this disease would be a healthy diet
with a mixture of wholegrains, fiber, fruits and vegetables, replacing saturated fats with
unsaturated fats, 120 minutes of standard physical activity a week. Other than the basic lifestyle
changes, additional treatment would suggest a cholesterol-lowering drug such as atorvastatin,
simvastatin, rosuvastatin which inhibits the enzyme within the liver that produces cholesterol or
niacin, which would be just as helpful with its ability to reduce triglycerides and raise HDL
levels. (Mandal)
Works Cited
Altmann, Scott W. "Scott W. Altmann - Figures & Descriptions ScienceWatch.com." Scott W. Altmann - Figures & Descriptions - ScienceWatch.com.
Thomson Reuters, Mar. 2008. Web. 05 Apr. 2016.
Brown, M. S., P. T. Kovanen, and J. L. Goldstein. "Result Filters." National
Center for Biotechnology Information. U.S. National Library of Medicine, 8 May 1981.
Web. 05 Apr. 2016.
Kantharia, Ajay. "Lipid Guidelines - Dr. Ajay Kantharia." Lipid Guidelines - Dr.
Ajay Kantharia. LinkedIn, 20 Apr. 2011. Web. 05 Apr. 2016.
Kresser, Chris. "The Diet-Heart Myth: Cholesterol and Saturated Fat Are Not the
Enemy." Chris Kresser. Chris Kresser, 19 Apr. 2013. Web. 05 Apr. 2016.
Mandal, Ananya. "Hypercholesterolemia Treatment." News-Medical.net. NewsMedical.net - An AZoNetwork Site, 18 Feb. 2010. Web. 05 Apr. 2016.
National Institute of Diabetes and Digestive and Kidney Diseases. "Livertox."
Bile Acid Resins or Sequestrants. U.S. National Library of Medicine, 3 May 2014. Web.
05 Apr. 2016.
Turley, Stephen D., and John M. Dietschy. "Medscape Log In." Medscape Log In.
Le Jacq Communications, Inc., 5 Apr. 2016. Web. 05 Apr. 2016.